Chemistry:1-Aminomethyl-5-methoxyindane
From HandWiki
Short description: Chemical compound
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C11H15NO |
Molar mass | 177.247 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
1-Aminomethyl-5-methoxyindane (AMMI), is a drug developed by a team led by David E. Nichols at Purdue University, which acts as a selective serotonin releasing agent (SSRA) and binds to the serotonin transporter with similar affinity to DFMDA.[1][2]
See also
References
- ↑ "Distinct molecular recognition of psychostimulants by human and Drosophila serotonin transporters". The Journal of Pharmacology and Experimental Therapeutics 308 (2): 679–87. February 2004. doi:10.1124/jpet.103.057836. PMID 14593087.
- ↑ "Comparative molecular field analysis using selectivity fields reveals residues in the third transmembrane helix of the serotonin transporter associated with substrate and antagonist recognition". The Journal of Pharmacology and Experimental Therapeutics 325 (3): 791–800. June 2008. doi:10.1124/jpet.108.136200. PMID 18354055.
Original source: https://en.wikipedia.org/wiki/1-Aminomethyl-5-methoxyindane.
Read more |